Stoke Therapeutics, Inc.
SEC CIK 1623526 · STOK · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Levin Arthur A | Director | filed 2019 - 2026 |
| Harrison Seth Loring | Director | filed 2019 - 2026 |
| Kaye Edward M. MD | Director · CEO | filed 2019 - 2026 |
| Smith Julie | Director | filed 2020 - 2026 |
| Tzianabos Arthur | Director · Interim Executive Chair | filed 2019 - 2026 |
| Burstein Jennifer | Director | filed 2019 - 2026 |
| Krainer Adrian R. | Director | filed 2019 - 2026 |
| Kahn Clare | Director | filed 2026 - 2026 |
| Smith IAN F | Director · Interim CEO | filed 2023 - 2026 |
| Menzel Garry E | Director | filed 2021 - 2025 |
| Hall Samuel W. | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Allan Jonathan | General Counsel & Corp Sec | filed 2023 - 2026 |
| Ticho Barry | Chief Medical Officer | filed 2019 - 2026 |
| Hoitt Jason | Chief Patient Officer | filed 2025 - 2026 |
| Leggett Thomas | Chief Financial Officer | filed 2024 - 2026 |
| Nash Huw M. | Chief Business Officer | filed 2019 - 2024 |
| Tulipano Stephen J | Former CFO | filed 2019 - 2024 |
| Liau Gene | EVP, Head of Research | filed 2019 - 2021 |
| Walker Robin A. | Chief Legal Officer, CCO & Sec | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.